Research
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine
-
* Corresponding author: Marta Maschio maschio@ifo.it
1 Center for tumor-related Epilepsy, Department of Neuroscience and Cervical- Facial Pathology, National Institute for Cancer "Regina Elena", Via Elio Chianesi 53, 00144 Roma, Italy
2 Department of Radiology, National Institute for Cancer "Regina Elena", Via Elio Chianesi 53, 00144 Roma, Italy
3 Department of Neuroscience and Cervical-Facial Pathology, National Institute for Cancer "Regina Elena", Via Elio Chianesi 53, 00144 Roma, Italy
4 Division of Clinical Oncology, National Institute for Cancer "Regina Elena", Via Elio Chianesi 53, 00144 Roma, Italy
Journal of Experimental & Clinical Cancer Research 2009, 28:60 doi:10.1186/1756-9966-28-60
Published: 6 May 2009Abstract
Background
Seizure control doesn't represent the only challenging goal in patients with brain tumor-related epilepsy. Side effects have often taken precedence for patients' quality of life.
Methods
We performed an observational retrospective study on patients with brain tumor-related epilepsy: 35 who had assumed oxcarbazepine monotherapy and 35 patients who had undergone treatment with traditional antiepileptic drugs. Primary variable of efficacy was the mean seizure frequency per month and safety variables were the drop-out for side effects and total incidence of side effects. We applied the Propensity Score technique to minimize selection bias.
Results
Our results showed a similar efficacy of oxcarbazepine and traditional antiepileptic drugs over time, but the difference in safety and tolerability between the two groups was significant: traditional AEDs caused more side effects, both serious and non serious.
Conclusion
This study highlights the importance of taking into consideration not only seizure control but also the appearance of side effects when choosing antiepileptic drugs in this patients population.